Skip to main content
ISTH 2024 Main banner
Back

Saskia Middeldorp, MD, PhD

Internist, Professor
Radboud university medical center
Nijmegen, Gelderland, Netherlands

Saskia Middeldorp, M.D. is Professor of Medicine and Head of the Department of Internal Medicine of the Radboud University Medical Center and one of the 4 Research Domain Leaders in the Radboudumc Research Institution for Medical Innovation in Nijmegen, The Netherlands.
Her present research focuses on several aspects of hereditary and acquired thrombophilia, women’s issues in thrombosis and haemostasis, and the clinical evaluation of new anticoagulants and antidotes. She is principal investigator of practice-changing trials such as the investigator-initiated ALIFE, ALIFE2 and Highlow randomized controlled trials.
Saskia Middeldorp is elected council member of the International Society of Thrombosis and Haemostasis, past chair of the INVENT-VTE network, Associate Editor of the Journal of Thrombosis and Haemostasis and Editorial Board Member of Blood.
In December 2016, she held the Ham-Wasserman Lecture and received the accompanying award in recognition of pioneering work in inherited thrombophilia at the annual American Society of Hematology (ASH) meeting in San Diego. In October 2021, she received the Heijmans van den Bergh penning, a once-per-five year honorary distinction of the Netherlands Internal Medicine Society for her achievements in terms of science, education, governance and being a role model for young internists.
She was chair of the Thrombophilia Chapter of ASH VTE Guidelines (2023). Saskia Middeldorp has co-authored the Pregnancy chapter of the ASH pregnancy guideline in 2018 as well as the 9th Edition Antithrombotic Guidelines of the American College of Chest Physicians (ACCP) in 2012.
Saskia has supervised and still supervises numerous PhD students and has co-authored over 425 peer-reviewed papers and several book chapters, and reviews manuscripts for international scientific journals.

Presentation(s):